Genetic Sequencing tests in Dubai & UAE

Compare available Genetic Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

256

Listed price range

2,600.00–5,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic Sequencing test prices

Showing 211–225 of 256 matching tests.

Genetic Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2308 SKI Gene Shprintzen‑Goldberg Syndrome Genetic Test This test detects pathogenic variants in the SKI gene associated with Shprintzen-Goldberg syndrome.	Peripheral Whole Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SKI gene", "Copy Number Variations (CNV) in the SKI gene"] Parameters [] Preparation [] Indications ["Suspected Shprintzen-Goldberg syndrome", "Family history of Shprintzen-Goldberg syndrome", "Presence of characteristic clinical features"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.8 Clinical summary This test detects pathogenic variants in the SKI gene associated with Shprintzen-Goldberg syndrome.
TEST-4170 SLC25A3 Gene Mitochondrial Phosphate Carrier Deficiency Genetic Test This test identifies pathogenic variants in the SLC25A3 gene, which are associated with mitochondrial phosphate carrier deficiency.	Whole blood (FTA card or EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC25A3 gene"] Parameters [] Preparation ["No fasting required", "Provide DHA-validated Emirates ID", "Provide signed consent (guardian for minors)", "Provide brief clinical history form"] Indications ["Suspected mitochondrial phosphate carrier deficiency", "Family history of related disorders", "Early diagnosis and risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 83306-2 ICD-10: E88.49 Clinical summary This test identifies pathogenic variants in the SLC25A3 gene, which are associated with mitochondrial phosphate carrier deficiency.
TEST-6326 SLC35A2 Gene Glycosylation Disorder Type 2M Genetic Test This test identifies pathogenic variants in the SLC35A2 gene, confirming a diagnosis of Congenital Disorder of Glycosylation Type II (CDG-II).	Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC35A2 gene", "Congenital Disorder of Glycosylation Type II (CDG-II)"] Parameters [] Preparation ["No fasting required", "Mandatory pre-test genetic counselling session", "Documentation of a three-generation pedigree"] Indications ["Suspected Congenital Disorder of Glycosylation Type II (CDG-II)", "Family history of CDG-II", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 102911-8 ICD-10: E77.8, R62.50, Z13.71 Clinical summary This test identifies pathogenic variants in the SLC35A2 gene, confirming a diagnosis of Congenital Disorder of Glycosylation Type II (CDG-II).
TEST-5736 SLC52A3 Gene (Brown-Vialetto-Van Laere Syndrome Type 1) Genetic Test This genetic test identifies pathogenic variants in the SLC52A3 gene associated with Brown-Vialetto-Van Laere syndrome type 1.	Whole Blood (EDTA), Extracted DNA, or FTA Card (Peripheral Blood)	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC52A3 gene", "Deletion/duplication analysis of the SLC52A3 gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of all current medications"] Indications ["Suspected Brown-Vialetto-Van Laere syndrome type 1", "Familial screening for riboflavin transporter deficiency"] Measurement technique Confirm with laboratory Codes LOINC: 81247-7 ICD-10: G12.29, H90.3, G71.8, Z15.01 Clinical summary This genetic test identifies pathogenic variants in the SLC52A3 gene associated with Brown-Vialetto-Van Laere syndrome type 1.
TEST-3500 SLC5A2 Gene Renal Glucosuria Genetic Test This genetic test identifies pathogenic variants in the SLC5A2 gene, confirming the diagnosis of familial renal glucosuria.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC5A2 gene", "Autosomal recessive familial renal glucosuria"] Parameters [] Preparation ["Do not discontinue prescribed medication without consulting your doctor.", "Inform your physician about any medications or supplements before testing."] Indications ["Suspected familial renal glucosuria", "Differentiation from diabetes mellitus", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 90401-5 ICD-10: E74.8 Clinical summary This genetic test identifies pathogenic variants in the SLC5A2 gene, confirming the diagnosis of familial renal glucosuria.
TEST-4803 SLURP1 Gene Mal de Meleda Genetic Test This test identifies pathogenic variants in the SLURP1 gene associated with Mal de Meleda.	Peripheral Whole Blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SLURP1 gene pathogenic variants", "Coding exons and flanking regions"] Parameters [] Preparation ["No fasting required", "Avoid blood-thinning medications unless approved by physician"] Indications ["Suspected Mal de Meleda", "Family history of Mal de Meleda", "Need for genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 21637-4 ICD-10: Q82.8 Clinical summary This test identifies pathogenic variants in the SLURP1 gene associated with Mal de Meleda.
TEST-4092 SMAD2 Gene Sequencing for Thoracic Aortic Aneurysm Dissection Test This test evaluates the SMAD2 gene for pathogenic variants associated with inherited thoracic aortic aneurysm and dissection syndromes.	Peripheral whole blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SMAD2 gene", "Exon and splice-site coverage"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medications without consulting your physician"] Indications ["Individuals with a family history of TAAD", "Young individuals with unexplained aortic dilatation", "Individuals with bicuspid aortic valve"] Measurement technique Confirm with laboratory Codes LOINC: 94037-6 ICD-10: I71.2, Z15.09 Clinical summary This test evaluates the SMAD2 gene for pathogenic variants associated with inherited thoracic aortic aneurysm and dissection syndromes.
TEST-5081 SMS Gene Snyder-Robinson Syndrome Genetic Test This test evaluates the SMS gene for pathogenic variants associated with Snyder-Robinson syndrome.	Whole Blood (EDTA) or Extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SMS gene coding region", "SMS gene splice sites", "Pathogenic variants in the SMS gene"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory.", "Signed informed consent form is required."] Indications ["Males with unexplained intellectual disability, hypotonia, seizures, and dysmorphic features.", "Individuals with a family history suggestive of X-linked intellectual disability.", "Carrier females seeking reproductive planning."] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: E70.8, F70 Clinical summary This test evaluates the SMS gene for pathogenic variants associated with Snyder-Robinson syndrome.
TEST-5854 SNAI2 Gene (Waardenburg Syndrome Type 2D) Next-Generation Sequencing (Genetic Test This genetic test analyzes the SNAI2 gene to detect variants associated with Waardenburg syndrome type 2D.	Peripheral whole blood (3–5 mL in EDTA lavender-top tube) or saliva (Oragene DNA collection kit)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SNAI2 gene variants", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variants (CNVs)"] Parameters [{"name": "Method Precision", "reference_range": "99.9% base-level accuracy"}] Preparation ["No dietary restrictions", "No supplemental modifications", "No medication adjustments required"] Indications ["Suspected Waardenburg syndrome type 2D", "Family history of Waardenburg syndrome", "Need for genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.0 Clinical summary This genetic test analyzes the SNAI2 gene to detect variants associated with Waardenburg syndrome type 2D.
TEST-4199 SNCA Gene Dementia & Lewy Body Genetic Test This test evaluates the SNCA gene for pathogenic variants associated with Lewy body dementia and Parkinson's disease dementia.	Whole blood, extracted DNA, or dry blood spot (FTA card)	3–4 weeks (21–28 days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SNCA gene pathogenic variants", "α-synuclein aggregation risk"] Parameters [] Preparation [] Indications ["Strong family history of Lewy body dementia or Parkinson's disease dementia", "Patients presenting with symptoms suggestive of synucleinopathies"] Measurement technique Confirm with laboratory Codes LOINC: 73518-2 ICD-10: G31.84 Clinical summary This test evaluates the SNCA gene for pathogenic variants associated with Lewy body dementia and Parkinson's disease dementia.
TEST-3449 SOX17 Gene Vesicoureteral Reflux Type 3 Genetic Test This test identifies genetic mutations in the SOX17 gene associated with Vesicoureteral Reflux Type 3.	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SOX17 gene pathogenic variants", "Single nucleotide variants", "Small indels", "Copy number variations"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant family history"] Indications ["Diagnosis of Vesicoureteral Reflux Type 3", "Family history of VUR3", "Assessment of familial risk"] Measurement technique Confirm with laboratory Codes LOINC: 21665-7 ICD-10: Q62.7 Clinical summary This test identifies genetic mutations in the SOX17 gene associated with Vesicoureteral Reflux Type 3.
TEST-3798 SP110 Gene Hepatic Veno-Occlusive Disease with Immunodeficiency Genetic Test This genetic test identifies disease-causing mutations in the SP110 gene associated with Hepatic Veno-Occlusive Disease with Immunodeficiency (VODI).	Peripheral Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SP110 gene", "Full coding region sequencing", "Copy number analysis"] Parameters [{"name": "SP110 Gene Sequencing", "reference_range": "No pathogenic variants detected"}] Preparation ["No specific fasting required", "Inform lab of any current medications"] Indications ["Suspected VODI based on clinical presentation", "Family history of VODI", "Evaluation of combined immunodeficiency and liver disease"] Measurement technique Confirm with laboratory Codes LOINC: 81314-5 ICD-10: D84.9 Clinical summary This genetic test identifies disease-causing mutations in the SP110 gene associated with Hepatic Veno-Occlusive Disease with Immunodeficiency (VODI).
TEST-3168 SPTB Gene Spherocytosis Type 2 Genetic Test This test identifies pathogenic mutations within the SPTB gene associated with Hereditary Spherocytosis Type 2.	Peripheral Whole Blood, FTA Card, or Isolated Genomic DNA	3 to 4 Weeks (19–28 Business Days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPTB gene", "Copy Number Variants (CNVs) in the SPTB gene"] Parameters [] Preparation ["Requires documented pre-test genetic counseling session", "Written informed consent and completed clinical history form including a three-generation pedigree are required"] Indications ["Suspected Hereditary Spherocytosis Type 2", "Family history of Hereditary Spherocytosis", "Need for precise diagnosis to guide treatment", "Cascade screening for at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 81316-6 ICD-10: D58.0 Clinical summary This test identifies pathogenic mutations within the SPTB gene associated with Hereditary Spherocytosis Type 2.
TEST-5069 SRCAP Gene Floating-Harbor Syndrome Genetic Test This test identifies pathogenic variants within the SRCAP gene associated with Floating-Harbor syndrome.	Whole Blood, Extracted DNA, or FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SRCAP gene", "Copy Number Variations (CNVs) in the SRCAP gene"] Parameters [] Preparation ["No fasting or special preparation is required."] Indications ["Suspected Floating-Harbor syndrome", "Syndromic short stature"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q87.1 Clinical summary This test identifies pathogenic variants within the SRCAP gene associated with Floating-Harbor syndrome.
TEST-6278 STT3A Gene Congenital Disorder of Glycosylation Type Iw Genetic Test This genetic test identifies pathogenic variants in the STT3A gene, confirming a diagnosis of Congenital Disorder of Glycosylation Type Iw (CDG-Iw).	Whole Blood (EDTA tube, 3–5 mL), Extracted DNA (minimum 1 µg at ≥50 ng/µL), or One Drop of Blood on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["STT3A gene sequence", "Pathogenic variants in STT3A"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant medications"] Indications ["Unexplained global developmental delay", "Axial hypotonia", "Abnormal coagulation profiles", "Characteristic type 1 transferrin isoform pattern", "Consanguinity", "Positive family history consistent with autosomal recessive inheritance"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: E77.8 Clinical summary This genetic test identifies pathogenic variants in the STT3A gene, confirming a diagnosis of Congenital Disorder of Glycosylation Type Iw (CDG-Iw).

Category overview

Genetic Sequencing: overview

Achieving a definitive diagnosis for multi-system or exceptionally rare disorders requires reading the deepest layers of your foundational biological code. As the pinnacle of our advanced Genetics department, Genetic Sequencing (including Whole Exome or Whole Genome testing) provides an incredibly detailed, high-resolution scan of your DNA. By leveraging state-of-the-art Next-Generation Sequencing technology, this expansive molecular screening helps uncover elusive genetic variants that standard tests miss, safely guiding your healthcare provider in tailoring highly personalized medical treatments and opening doors to advanced precision medicine. Consistently trusted for advanced genomic analysis across premier diagnostic labs in Dubai and the UAE, DNA Labs ensures strict patient confidentiality, exceptional analytical precision, and highly efficient reporting. Secure the definitive insights your health requires—book your genetic sequencing testing in UAE, arrange a secure clinical sample collection, or consult our dedicated medical genetics experts.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.